“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia”-Reference-Cited by-同舟云学术

“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia”

Published:2017 Issue: Volume:7 Page:11-13
ISSN:2213-0489
Container-title:Leukemia Research Reports
language:en
Short-container-title:Leukemia Research Reports

Author:

Cavallari Maurizio,Ciccone Maria,Falzoni Simonetta,Cavazzini Francesco,Formigaro Luca,Di Virgilio Francesco,Rotola Antonella,Rigolin Gian Matteo,Cuneo Antonio

Funder

Italian Association for Cancer Research

Ministry of Health of Italy

Italian Ministry of Education, University and Research

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference10 articles.

1. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL;Matutes;Leukemia,1994

2. Adult haemophagocytic syndrome;Ramos-Casals;Lancet,2014

3. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy;Teachey;Blood,2013

4. Toxicity management for patients receiving novel T-cell engaging therapies;Barrett;Curr. Opin. Pediatr.,2014

5. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis;Allen;Pediatr. Blood Cancer,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Chronic Lymphocytic Leukemia Complicated by Hemophagocytic Lymphohistiocytosis: Identifying the Aberrant Immune Response;Journal of General Internal Medicine;2022-02-17

2. Cytomegalovirus and Epstein-Barr Infections: Prevalence and Impact on Patients with Hematological Diseases;BioMed Research International;2020-10-26

3. Ibrutinib‐associated hemophagocytic lymphohistiocytosis: A case series from Johns Hopkins;American Journal of Hematology;2019-08-22

4. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL);Leukemia;2019-01-30

5. Ibrutinib;Reactions Weekly;2017-03